fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

European Commission approves EUR Neffy (epinephrine nasal spray) for emergency treatment of severe allergic reactions in adults and children – ARS Pharma

Written by | 7 Sep 2024

ARS Pharmaceuticals, Inc. announced the European Commission’s approval of EURneffy for emergency treatment of severe allergic reactions in adults and children weighing at least 30 kilograms. This approval… read more.

FDA approval of neffy (epinephrine nasal spray), the first and only needle-free treatment for type I allergic reactions, including anaphylaxis – ARS Pharmaceuticals

Written by | 10 Aug 2024

ARS Pharmaceuticals, Inc. , a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect patients from severe allergic reactions that could lead to anaphylaxis, announced… read more.

Measuring skin water loss predicts anaphylaxis during food allergy tests

Written by | 12 Nov 2023

Food allergies can quickly turn a casual meal into a life-threatening situation. Anaphylaxis – a severe allergic reaction that may include a skin rash, nausea, vomiting, difficulty breathing,… read more.

Only 52% of adults with severe food allergy have been prescribed an epinephrine auto injector

Written by | 14 Nov 2022

Epinephrine is the only medication that can stop anaphylaxis and it is critical that everyone with a food allergy has access to epinephrine to treat life threatening reactions…. read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.